Approvals & regulatory · first seen 23h ago, updated 8h ago
GRAIL's Galleri test wins endorsement from FDA panel
Even though the molecular and clinical genetics devices panel of the medical devices advisory committee for the U.S. FDA voted in favor of Grail Inc.’s Galleri multi-cancer early detection test, a number of concerns were raised over its saf…
Summary from BioWorld Articles.
Coverage 2 articles · 2 outlets
-
Seeking Alpha HealthcareGRAIL's Galleri test wins endorsement from FDA panel
-
BioWorld ArticlesGrail’s Galleri test gets FDA panel vote but concerns remain